Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |